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Figure 4. Clobetasol treated LT cells proliferate at 
similar rates as controls. LT Clob10d cells had similar 
BrdU incorporation (panel A) and Ki67 levels (panel B) 
relative to Ethanol treated cells (control). When removed 
from clobetasol, Clob6d-4d, cells had higher proliferation 
rates than controls.  
Vulvar cancer is rare, mostly afflicting women 
aged 60 and older [1]. The cancer is often 
preceded by a common vulvar rash, Lichen 
sclerosis, that is usually treated with the 
ultra-potent corticosteroid, clobetasol 
propionate. This treatment may, in turn, be 
associated with vulvar carcinogenesis. 
Quiescence, a common characteristic of stem 
cells, is a reversible state of growth arrest. Our 
results suggest that clobetasol is causing 
UMSCV-4 vulvar carcinoma cells to enter 
quiescence, and may allow them to evade the 
standard treatments that target rapidly 
proliferating populations.  Furthermore, when 
these cells are removed from clobetasol and 
re-exposed, they proliferate at higher levels. 
This suggests that the initial clobetasol 
treatment selects for cells that are now unable 
to enter quiescence when re-exposed to 
clobetasol.
INTRODUCTION
Figure 2.  Clobetasol treated NT cells (A), but not LT 
cells (B), experienced relatively higher cell death 
when compared to controls grown in ethanol. 
Percentage of cell death was measured using a trypan 
blue exclusion assay in UMSCV-4 cells exposed to 
medium containing EtOH in the control group, or 
clobetasol. Two groups of SCV4 cells were examined: 
long term cells grown in clobetasol for >3 months and no 
treatment cells grown in normal medium. Cells with long 
term exposure to clobetasol (panel A) exhibited 
considerably lower rates of death when grown with 
clobetasol compared to the no treatment cells (panel B)  
(* =  Significance).
MATERIALS & METHODS
RESULTS
❏   Clobetasol treatment lead to increased cell death   
in UMSCV-4 cell subpopulations that were not 
previously exposed to clobetasol (NT).
❏  Clobetasol treatment lead to decreased proliferation 
in UMSCV-4 cell subpopulations that were not 
previously exposed to Clob (NT). This could be 
reversed within 4 days if cells were removed from 
Clob after 6 days treatment.   
❏   UMSCV-4 cells that were treated for 3 months with 
clobetasol, then removed, and re-exposed (LT) 
showed similar proliferation rates when treated with 
clobetasol, ethanol, or clobetasol short term.  
❏   NT cells had upregulation of cell cycle inhibitors, 
p16 and p21 while downregulation of cyclin D1 after 
10 days of clobetasol treatment, indicating a negative 
change in the proliferation 
❏  Long term exposure to clobetasol may select for 
cells that are resistant to the antiproliferative effects 
of clobetasol.
                                                                                                                                                                                                                                                                                                          
CONCLUSION
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Clobetasol-induced quiescence in the vulvar carcinoma cell line, UMSCV-4 can be 
overcome by repeated removal and re-exposure to this ultrapotent corticosteroid
A.           B.
A.        B.  
FURTHER STUDIES
❏ Studies are now aimed at defining the growth rate of 
surviving cells post initial clobetasol treatment.  
❏ Further research will focus on repeating RT-qPCR 
experiments and trypan blue exclusion assays on NT 
cells and LT cells to gather more definitive data. 
A.        B.
Cell death assays (trypan blue) and immunofluorescence 
detection of the proliferation markers Ki67 as well as BrDU 
incorporation were used to determine rates of proliferation 
in the clobetasol treated UMSCV-4 cells.  In addition, cells 
were examined for changes in mRNA expression of key 
markers indicative of entering a state of quiescence. 
Clobetasol was diluted in 95% ethanol (10-7 M  final 
concentration) and UMSCV-4 cells were cultured in the 
presence (+clob) or absence of clobetasol (-clob) for these 
experiments.  UMSCV-4 LT cell populations were generated 
as described in Figure 1.
The basic procedure for examination of clobetasol effects 
on UMSCV-4 NT and UMSCV-4 LT cells was as follows
❑ EtOH 10d: Ethanol treated for 10 days 
❑ Clob10d: Treated with clobetasol for 10 days 
❑ Clob 6d-4d: Treated with clobetasol for 6 days and 
changed to ethanol medium for 4 days 
Cells from each group were subsequently harvested and 
tested using protocols described in each figure.. 
CONCLUSIONS
Figure 3. Clobetasol treated NT cells had lower 
proliferation rates relative to controls. BrdU incorporation is 
a measure for relative DNA replication amounts and 
corresponds to proliferation rate. Ki67 is a proliferation 
associated protein that, as with BrdU, is detected with 
immunofluorescence (Figure 3A &3B ) and Image J [3]. 
Clob10d cells had lower BrdU incorporation and Ki67 relative 
to ethanol treated cells (control). When removed from 
clobetasol, Clob6d-4d, cells had proliferation rates increase to 
levels similar to controls. 
Figure 5. Clobetasol treated NT Cells express lower 
levels of proliferation associated proteins and higher 
inhibitory proteins. RT-qPCR gene expression analysis 
shows increased levels of p16 and p21 Cdk inhibitors. 
Additionally, Cyclin D1 is decreased. Cdk2, Cdk4 and 
Cyclin E were increased, however this may be related to 
quiescence progression. 
Figure 1.  Re-exposure of UMSCV-4 cells to clobetasol 
results in resistance to the growth inhibition effects of 
clobetasol. This model represents the process that led to 
generation of the long-term, clobetasol resistant UMSCV-4 
cells.  Untreated UMSCV-4 cells were exposed to 
clobetasol for 3 months during which time the clobetasol 
medium was refreshed periodically to account for 
evaporation but the cells were not removed or passaged.  
After 3 months the clobetasol was removed and cells were 
allowed to “recover” for 4 weeks.  Note that mitotic cells 
were visible within 3 days of clobetasol removal.  After 4 
weeks proliferating cells were re-exposed to clobetasol.  
These cells did not experience the growth arrest seen 
when originally exposed to clobetasol.  This population of 
cells is referred to as UMSCV-4 LT.   
